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Background/aim: Broad-spectrum antibiotics have become available for use only with the approval of infectious disease specialists 
(IDSs) since 2003 in Turkey. This study aimed to analyze the tendencies of doctors who are not disease specialists (non-IDSs) towards 
the restriction of antibiotics. 
Materials and methods: A questionnaire form was prepared, which included a total of 22 questions about the impact of antibiotic 
restriction (AR) policy, the role of IDSs in the restriction, and the perception of this change in antibiotic consumption. The questionnaire 
was completed by each participating physician. 
Results: A total of 1906 specialists from 20 cities in Turkey participated in the study. Of those who participated, 1271 (67.5%) had 
≤5 years of occupational experience (junior specialists = JSs) and 942 (49.4%) of them were physicians. Specialists having >5 years of 
occupational experience in their branch expressed that they followed the antibiotic guidelines more strictly than the JSs (P < 0.05) and 
755 of physicians (88%) and 720 of surgeons (84.6%) thought that the AR policy was necessary and useful (P < 0.05).
Conclusion: This study indicated that the AR policy was supported by most of the specialists. Physicians supported this restriction 
policy more so than surgeons did. 
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1. Introduction
Antibiotics are one of the most valuable, crucial, and 
life-saving drugs of the last century. However, antibiotic 
resistance emerged right after their usage, and today this 
problem threatens the world. In addition, the uncontrolled 
and irrational usage of antimicrobials has increased 
treatment costs. Moreover, treatment failures may occur 
due to infections caused by antibiotic-resistant bacteria 
(1,2). Today, the number of newly discovered antibiotics 
is quite limited. Thus, new strategies to protect antibiotics 
should be considered.
In Turkey, antibiotics constitute 15%–20% of all 
prescribed drugs (3). Antibiotics have been number one on 
the list of the most commonly used drugs for many years. 
The main reasons behind their unnecessary and irrational 
usage may be related to a lack of knowledge on antibiotics 
due to shortcomings in medical training, pressure and 
promotions by the pharmaceutical industry, the absence of 
an antibiotic policy, and national antibiotic guidelines (4). 
The restriction of certain broad-spectrum antibiotics is an 
important strategy for the rational usage of antibiotics. An 
antibiotic restriction (AR) policy was shown to enhance 
the “rational usage” of antibiotics and to reduce financial 
expenditure (5).
Before 2003, every specialist in Turkey was able to 
prescribe any antibiotic. However, a law enacted in 2003 
stipulated that certain broad-spectrum antibiotics (such 
as carbapenems, vancomycin, teicoplanin, linezolid, 
daptomycin, piperacillin/tazobactam, etc.) could only 
be prescribed with the approval of an infectious disease 
specialist (IDS). In brief, if a patient was to be given 
a certain broad-spectrum antibiotic, it could only be 
prescribed after the approval of an IDS. This AR policy 
forms two groups of specialists: IDSs and doctors who 
are not infectious disease specialists (non-IDSs). This 
creates a negative perception among non-IDSs. While 
some non-IDSs consider this approach positive and 
useful, the majority of non-IDSs feel that it is useless and 
that it hampers patient services, or that it might restrict 
specialists’ rights (6). 
What kind of an impact did the AR policy have on 
non-IDSs? The literature search that we conducted did not 
reveal any relevant studies. The aim of this study was to 
examine how the AR policy is perceived by non-IDSs and 
what kind of behavioral changes it caused. This study is 
the first to be carried out in the 8 years since the AR law 
passed.
2. Materials and methods
2.1. Study design
This was a multicenter study conducted between August 
and December 2011. In sample size calculation, the 
approach of achieving a number of participants 50 times 
greater than the number of scale items used in scale studies 
was preferred. We planned to conduct the study with 1000 
participants from each junior and senior specialist group 
because there were 20 items on the scale. For the study 
data to be homogeneously distributed over the country, 39 
tertiary hospitals from different cities in several regions of 
Turkey were determined. The IDSs of those centers were 
contacted via email and were invited to participate in the 
study. The centers were asked to reply to the invitation 
within 1 month. Of these centers, 27 replied affirmatively. 
A questionnaire as well as an electronic form prepared 
for the centers to note down the results were sent to the 
participating centers via email. Each center was asked to 
contact 50 surgeons and 50 physicians, conduct a face-to-
face interview to complete the questionnaire forms, and 
record the answers electronically. Finally, the collected 
forms were emailed to the coordinating center. Specialists 
with ≤5 years of professional experience after the specialty 
period were considered “junior specialists” (JSs), and those 
with >5 years of professional experience were considered 
“senior specialists” (SSs).
2.2. Survey
The first part of the questionnaire included questions 
about demographic data, such as the area of specialization, 
sex, duration of work in the profession or in the area of 
specialization, current place of employment (state hospital, 
training hospital, university hospital, private hospital), and 
whether the hospital had an IDS or not.
In the second part of the questionnaire, the Scale of 
Specialists’ Perception Regarding Antibiotic Restriction 
(SSPRAR) was used to examine the changes in AR 
brought by the Health Application Communique (HAC) 
and the role of the IDS in the restriction and antibiotic 
consumption. Two open-ended questions in the scale 
evaluated the knowledge of the participants on rational 
usage of antibiotics and their behavior when they needed 
to prescribe antibiotics requiring IDS approval.
2.3. SSPRAR
This is a scale developed by the research team that included 
questions to be answered by non-IDSs. It initially included 
20 items but was later reduced to 14 items through 
reliability analysis. Respondents were expected to rate each 
item using a 5-point Likert type scale (4 = strongly agree, 3 
= agree, 2 = disagree, 1 = strongly disagree, 0 = indecisive). 
The scale was evaluated by reliability analysis for 
internal consistency and the Cronbach alpha coefficient 
was calculated (7,8). The scale was evaluated in terms 
of additivity with Tukey’s test of additivity, and the 
comparisons between groups were made over total scale 
scores (8).
Since the 14 items of the scale showed additivity 
according to Tukey’s test of additivity (P = 0.148), the 
scores of the items constituting the scale were added up. 
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Because the scale consisted of 14 items and the highest 
score of each item was 4, the maximum score that could 
be obtained from the scale was calculated as 56. Since it 
would be easier to interpret scores over a total score of 
100, the score obtained by each specialist was multiplied 
by the ratio of 100/56 and was evaluated over a total score 
of 100 to calculate the specialist perception scores (100 = 
the score that represents the most positive perception).
2.4. Statistical methods
Since a normal distribution condition was not provided 
by the Kolmogorov–Smirnov normality test, the Mann–
Whitney U test was used in the comparisons between 
groups in terms of the scale scores used in the study. The 
scale scores were shown with median and interquartile 
range. A chi-square test was used in the comparisons 
between the groups for categorical variables. The odds ratio 
was calculated by taking JSs as a reference for the duration 
of specialty, and surgeons and physicians in the field of 
specialty. Categorical variables were shown as numbers 
and percentages. P-values below 0.05 were considered 
statistically significant. The calculations were made with 
IBM SPSS Statistics 20 (IBM Corp., USA) software.
2.5. Ethical approval 
This study was planned as a multicenter prospective 
study. The study was approved by the Medical Ethics 
Board of Abant İzzet Baysal University (2011/B.30.2.A
BU.0.20.05.04-050.01.0468). All participants were verbally 
informed before completing the questionnaires.
3. Results
3.1. Demographical features
A total of 27 centers accepted the invitation, but two of 
them did not send any data. Consequently, the study was 
completed with the participation of 25 centers and 1906 
specialists (581 females, 1325 males) from different parts 
of Turkey. Of the participants, 1271 specialists (67.5%) 
were JSs, while 611 (32.5%) were SSs. Twenty-four 
specialists did not state their duration of experience. Of the 
applicants, 942 (49.4%) were physicians and 964 (50.6%) 
were surgeons. The average work-related experience 
of the specialists in the profession was 10.3 years; 1036 
participants (54.4%) were working in university hospitals, 
737 (38.5%) in training and research hospitals, 119 (6.2%) 
in secondary state hospitals, and 14 (0.7%) in private 
hospitals. Of the participants, 1895 (99.4%) were working 
in centers with IDSs. 
3.2. Results regarding the enforcement of the HAC rules
In total, 77.7% of the participants thought that the HAC 
rules were necessary, 69.9% that AR policy had a positive 
effect on the budget, and 63.3% that the HAC reduced 
the unnecessary use of antibiotics. In addition, 19.7% of 
the specialists thought that the choice of antibiotics after 
the AR policy was more consistent with the guidelines 
compared to the pre-AR period. The great majority 
(79.1%) of the participants assumed that IDS consultation 
augmented the antibiotic usage quality. A total of 49.2% of 
the participants felt that IDS approval results in delayed 
initiation of antibiotic treatment. When they were obliged 
to prescribe an antibiotic subjected to the restriction, 
14.4% of the specialists prescribed an unrestricted 
antibiotic, while 83.8% asked for an IDS consultation in 
such a situation. Participant answers are summarized in 
Figure 1.
SSs thought that their antibiotics knowledge was 
better compared to JSs (P < 0.05). Similarly, the number 
of surgeons thinking that they had sufficient knowledge 
on antibiotics was higher than the physicians (P < 0.05). 
The opinion that excessive antibiotic usage increased with 
IDS consultation was 33.8% among surgeons and 28.5% 
among physicians (P < 0.05). The distribution of the 
answers according to professional experience is shown in 
Figure 2 and according to branches in Figure 3.
The internal reliability coefficient (Cronbach alpha) 
of the SSPRAR was calculated as 0.835. Item–total 
correlations were between 0.265 and 0.568. Accordingly, 
there was a moderately significant relation between the 
items and the total scale. Therefore, the SSPRAR was 
considered a reliable scale.
In general, the SSPRAR is a valid, reliable test with 
high differential power that can be used in the evaluation 
of non-IDSs’ perception regarding AR policy. A significant 
difference was found in terms of the SSPRAR between total 
scores according to branches and professional experience 
(respectively P < 0.001 and P < 0.05) (Table).
4. Discussion
There is a limited number of studies regarding AR rules for 
specialists in Turkey. To our knowledge, this study is the 
first to explore the impact of nationwide AR through the 
participation of different centers. The results of this study 
showed that 78% of the non-IDS participants thought 
that AR policy was necessary. Most non-IDS participants 
also supported such a restriction. The main reason for 
this may be the increasing rates of antibiotic resistance in 
bacteria. Although non-IDSs think that this restriction is a 
limitation of their practice, they are also aware of the risk 
presented by antibiotic-resistant bacteria. Therefore, they 
are willing to accept the idea that antibiotics, and especially 
broad-spectrum antibiotics, should only be prescribed by 
specialists in this area (9).
This study, which was conducted years after the 
initiation of the implementation of AR policy, showed 
that restricted specialists supported the transfer of this 
responsibility. Moreover, 69% of the participants thought 
that IDS-approved AR had reduced the cost of antibiotic-
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Figure 1. The views of noninfectious disease specialists on antibiotic restriction.
Figure 2. The views of specialists on budget application direction and the mandatory infectious disease and clinical microbiology 
specialist approval for certain antibiotics, according to their duration of experience in the area of specialty.
137
KARABAY et al. / Turk J Med Sci
related therapy and 63% thought that this approach 
reduced antibiotic consumption. All these data also 
confirm that non-IDSs support this policy.  
According to the SSPRAR used in this study, SSs had 
a more favorable attitude towards the AR policy, whereas 
the perception that the restriction was unnecessary was 
more common among JSs, which may be attributed to 
their unawareness of the resistance threat. We feel that 
they would be more cooperative and would not see the 
restriction as a limitation of their antibiotic prescription 
freedom if they were better informed about and aware of 
this threat (10).
According to the SSPRAR, the negative perception 
of the AR policy among surgeons was much higher than 
among physicians. Furthermore, the need for current 
guidelines for prescription of antibiotics was significantly 
higher among physicians than among surgeons (85% versus 
78%, P < 0.05). This may be attributed to the surgeons’ 
antibiotic-prescribing habits (11). In addition, SSs refer 
to guidelines more often while prescribing antibiotics, 
whereas JSs need less reference to guidelines (85.3% versus 
79.5%, P < 0.05). However, SSs think that their knowledge 
on antibiotics is sufficient, while JSs find it insufficient. 
The reason why experienced specialists consider their 
knowledge on antibiotics sufficient might be due to the fact 
that they refer to guidelines more often. In addition, the 
fact that JSs refer to the guidelines less frequently might 
be related to the fact that they have developed the habit 
of transferring the decision of prescribing broad-spectrum 
antibiotics to IDS consultations. Another reason might 
Figure 3. The distribution of the specialists’ replies to the queries in the survey according to surgical and medical science branches.
Table. The results of the restriction according to the Scale of Physicians’ Perception Regarding Antibiotic Restriction (SSPRAR).
Parameters N (%)
SSPRAR total score
P-valueMedian [IQR] Min–max
Specialty
Internal medicine 942 (49.4) 69.64 [53.57–83.93] 20–100
<0.001
Surgical 964 (50.6) 66.07 [50.00–80.36] 00–100
Sex
Female 581 (30.5) 67.86 [50.00–83.93] 5.36–100
0.928
Male 1325 (69.5) 67.86 [51.79–82.14] 20–100
Experience
Junior physicians 1271 (67.5) 66.07 [50.00–82.14] 0–100
<0.05
Senior physicians 611 (32.5) 69.64 [53.57–83.93] 0–100
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be the idea that SSs are familiar with the effects and side 
effects of antibiotics, since they were freely prescribing 
antibiotics for years. As far as prescribing antibiotics after 
IDS consultations is concerned, JSs might not be interested 
in learning more about the subject (6).
The opinion that IDS consultations increase the 
prescription of unnecessary and broad-spectrum 
antibiotics was held more often by surgeons than 
physicians (33.8% versus 28.3%, P < 0.05). This might be 
related to the lack of communication between IDSs and 
surgeons, the surgeons’ antibiotic-prescribing habits, and 
the surgical infections associated with this application. In 
addition, while the majority of bacteria were sensitive to 
many antibiotics in the early 2000s, antibiotic resistance 
rates of bacteria known to cause hospital infections are 
very high nowadays (12). 
In total, 49.2% of the participants thought that the AR 
policy requiring IDS approval delayed the initiation of 
antibiotic treatment. Moreover, there was no difference 
between surgeons and physicians or between JSs and SSs 
in this respect. Consultations in hospitals require several 
procedures, and sometimes it may take 1–6 h to conclude 
a consultation in busy hospitals (6). In serious conditions 
such as sepsis, the delayed initiation of antibiotic treatment 
due to prolonged consultation times may risk the life 
of the patient (13). Therefore, IDSs should attend the 
consultations as quickly as possible, especially in cases of 
patients with infectious emergencies (14).
Our study has some limitations. First, we asked 
clinicians who assumed that the AR policy is rational and 
reasonable and who had good relations with the IDS to 
participate in the study, leading to a bias in the selection 
of study participants. Second, the number of specialists 
working in secondary state hospitals and in private 
hospitals who participated in our survey was smaller 
than the number of the participants who were working 
in tertiary-care hospitals. Thus, we might not have been 
able to accurately compare the views of specialists in 
secondary- and tertiary-care hospitals on AR policy.
In conclusion, the restricted usage of antibiotics is 
favored by four-fifths of non-IDSs who agree that this 
approach reduces costs. Physicians support this restriction 
more so than surgeons. However, it is important to note 
that the AR policy requiring the IDSs’ approval is perceived 
to delay the initiation of antibiotic treatment. Hence, there 
is a need for new policies that will increase the cooperation 
between IDSs and other branch specialists and that will 
encourage the rational usage of antibiotics.
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